We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I am not misleading! I have level 2 as well.
What is your problem?
SAD...why mislead?? You don't have L2, clearly...sp is increasing, 23p❗
RF have been forward selling imho...forget 'offloading' now!
Looks like RF unloading a few now.
All will be fine.
Regards
Exactly and just look at the AZ deal last month to acquire Amolyt Pharma, after its data for Eneboparatide proved enough for AZ to pay $1.05 billion in cash, with $800 million upfront. That's yet another $1 Billion+ deal for a small clinical stage company....
Good luck, Brighty
Again, still one of the best buys on LSE, long way to go and the herd are arriving
21...and it's only Wednesday 😎
Have bought more...perfect time .
Wow Basil, someone has an amazing memory!!
Daughters wedding got cancelled due to Covid and then got pregnant lol so next year now!
Well done the BoD - Parker in!! (Works both ways - just for balance)
Well, we are Rampworthy 😁 No stopping us now...soon be back up at more respectable sp levels...
Right now, about to say hello to 20...by Friday COP 30+ without news. WITH news? The sky is large!
Agree this is one of the best buys and will continue to rise up
Hi PhilBoro, wasn't it a top of the range F Type Jag you acquired with the gains made on the last Sareum rise plus a donation to Cancer Research and your daughter's wedding. I hope it happens again here for you. Your story always made me realise it was about the bigger picture. Come on Sareum lets see 100p soon. With positive news that's more than possible.
Philboro- Nice to see you back on the board
Surely we have earned a ramp 😊
Haha cheers
Lol yes I know PHILBORO, I meant Wiggly! Should have made it clearer, sorry. Feel free to have a good old ramp though, it's that kind of day!
Dr Harry Finch, the co-inventor of the asthma drug Salmeterol, was / is a mentor to our CSO John Reader and is regarded in the pharma sector as a patent's guru. i.e. 50+ patents to his name. Dr Finch, Dr Owen and Dr Mitchell are old school GSK guys. It's why I'm still invested in Sareum. They are proven winners ....
Good luck, Brighty
See you are in AVCT Wiggly .. share price by pattern almost same as SAR peak in mid 2021 .. terrible since then .. but SAR is on the rise again exciting times we know what it is capable of!! So glad I got the chance to top up at just over 10p!!
New ramper lol, been in SAR over 12 years mate
Exactly Phil and there's real depth to this investment when you dig a little further. e.g. for those that are not aware our CEO Tim Mitchell is the inventor of Oblean® (cetilistat) which Takeda did a colloboration with from Norgine following the Alizyme Therapeutics deal. i.e. Takeda and the close knit pharma sector in which Sareum operate in will be fully aware of how good a scientist Tim Mitchell is. All eyes are now waiting on a 7 am RNS regarding the 1801 trial in Australia and then hopefully a partnership with a global pharma....
Good luck, Brighty
52 week high 150!
《90m shares free float.
Could really take off from this level.
Thank God, a new ramper. Give us all a break. Keep up the good work fella, don't stop til £10 at least.
52 week high 150!
And good to know that there is absolutely no need to issue a speeding ticket under any circumstances.
36-50p would appear to be very achievable in the short term